Today's Change
+0.85%
AI Sentiment
62%
Sector AnalysisLive data
Materials Sector Outlook
The Materials sector is up 0.85% today with bullish sentiment across 14 recent news articles. Top movers include $CDTTW (+65.33%), $ERNAW (+63.87%), $TMCWW (+60.68%).
Bullish Factors
- No strong bullish signals detected
Risk Factors
- No strong bearish signals detected
Stocks in Materials
198 stocks| Symbol | Company | Change |
|---|---|---|
| $BCTXZ | BriaCell Therapeutics Corp. Warrant | -13.56% |
| $RVMDW | Revolution Medicines, Inc. Warrant | +4.86% |
| $TMCWW | TMC the metals company Inc - Warrants (09/09/2026) | +60.68% |
| $CINGW | Cingulate Inc. Warrants | -10.38% |
| $ENGNW | enGene Holdings Inc - Warrants (31/10/2028) | +11.50% |
| $SDSTW | Stardust Power Inc - Warrants (21/06/2029) | -2.69% |
| $SCLXW | Scilex Holding Company - Warrants (10/11/2027) | -6.43% |
| $SBFMW | Sunshine Biopharma Inc - Warrants (15/02/2027) | +0.00% |
| $NAMSW | NewAmsterdam Pharma Company NV - Warrants (15/11/2027) | +21.31% |
| $ERNAW | Ernexa Therapeutics Inc. Warrants | +63.87% |
| $KTTAW | Pasithea Therapeutics Corp. Warrant | -1.23% |
| $TVGNW | Tevogen Bio Holdings Inc. | +12.66% |
| $CDIOW | Cardio Diagnostics Holdings Inc | -11.72% |
| $DRMAW | Dermata Therapeutics Inc - Warrants (13/08/2026) | -8.87% |
| $JSPRW | Jasper Therapeutics Inc - Warrants (24/09/2026) | -15.64% |
Materials News
807 articles
GlobeNewswire Inc.37d ago
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026
GlobeNewswire Inc.37d ago
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 mars 2026
Benzinga37d ago
Athyrium Capital Management and Esperion Enter Into $50 Million Japan Royalty Financing to Support Strategic Acquisition of Corstasis Therapeutics
GlobeNewswire Inc.37d ago
Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)
GlobeNewswire Inc.37d ago
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Corcept Therapeutics Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – CORT
Benzinga37d ago
Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy
GlobeNewswire Inc.37d ago
Perspective Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.37d ago
ScottsMiracle-Gro Reaffirms Fiscal 2026 Guidance; Margin Recovery and Growth Plans Remain on Track
Market Sentiment
Bullish
62% Sentiment Score
Sector Stats
Total Stocks198
News Today14
Avg Volume1.3M
AI SentimentBullish